master medic drugs Ind CI PC to MAY25

Card Set Information

Author:
thom.mccusker@gmail.com
ID:
88671
Filename:
master medic drugs Ind CI PC to MAY25
Updated:
2011-06-22 10:45:11
Tags:
master medicdrugs Ind CI PC MAY25 medic12
Folders:

Description:
master medicdrugs Ind CI PC to MAY25 medic12
Show Answers:

Home > Flashcards > Print Preview

The flashcards below were created by user thom.mccusker@gmail.com on FreezingBlue Flashcards. What would you like to do?


  1. Albuterol
    • Ind: Brochospasm and asthma in COPD
    • CI: Hypersensitivity
    • PC: 1) tachycardia 2) anxiety 3) nausea 4) cough 5) wheezing 6) dizziness
  2. Ind: Brochospasm and asthma in COPD
    CI: Hypersensitivity
    PC: 1) tachycardia 2) anxiety 3) nausea 4) cough 5) wheezing 6) dizziness
    Albuterol
  3. Fentanyl
    • Ind: Induce sedation for endotracheal intubation
    • CI: 1) MAO inhibitors within 14 days 2) myasthenia gravis
    • PC: 1) increased intracranial pressure 2) elderly 3) debilitated 4) COPD 5) respiratory problems 6) hepatic and renal insufficiency
  4. Ind: Induce sedation for endotracheal intubation
    CI: 1) MAO inhibitors within 14 days 2) myasthenia gravis
    PC: 1) increased intracranial pressure 2) elderly 3) debilitated 4) COPD 5) respiratory problems 6) hepatic and renal insufficiency
    Fentanyl
  5. Ipratropium
    • Ind: 1) bronchospasm associated with asthma 2) COPD 3) inhaled irritants
    • CI: 1) hypersensitivity to atropine or its derivatives 2) as a primary treatment for acute bronchospasm 3) nut allergy
    • PC: 1) elderly 2) cardiovascular disease 3) hypertension
  6. Ind: 1) bronchospasm associated with asthma 2) COPD 3) inhaled irritants
    CI: 1) hypersensitivity to atropine or its derivatives 2) as a primary treatment for acute bronchospasm 3) nut allergy
    PC: 1) elderly 2) cardiovascular disease 3) hypertension
    Ipratropium
  7. Morphine Sulfate
    • Ind: 1) moderate to severe pain & 2) in MI & 3) to reduce venous return in pulmonary edema
    • CI: 1) hypersensitivity to opiates 2) undiagnosed head or abdominal injury 3) hypotension or volume depletion 4) acute bronchial asthma 5) COPD 6) severe respiratory depression 7) pulmonary edema due to chemical inhalation
    • PC: 1) elderly 2) children 3) debilitated [naloxone available to counteract effects of morphine]
  8. Ind: 1) moderate to severe pain & 2) in MI & 3) to reduce venous return in pulmonary edema
    CI: 1) hypersensitivity to opiates 2) undiagnosed head or abdominal injury 3) hypotension or volume depletion 4) acute bronchial asthma 5) COPD 6) severe respiratory depression 7) pulmonary edema due to chemical inhalation
    PC: 1) elderly 2) children 3) debilitated [naloxone available to counteract effects of morphine]
    Morphine Sulfate
  9. Naloxone
    • Ind: 1) narcotic overdose 2) coma of unknown origin
    • CI: 1) hypersensitivity to the drug 2) non-narcotic induced respiratory depression
    • PC: 1) possible dependency (including newborn) 2) shorter half-life than narcotics: (pt may relapse)
  10. Ind: 1) narcotic overdose 2) coma of unknown origin
    CI: 1) hypersensitivity to the drug 2) non-narcotic induced respiratory depression
    PC: 1) possible dependency (including newborn) 2) shorter half-life than narcotics: (pt may relapse)
    Naloxone
  11. DIAZEPAM
    • Ind: 1) major motor seizures 2) status epilepticus 3) premedication before cardioversion 4) muscle tremors due to injury 5) acute anxiety
    • CI: 1) shock 2) coma 3) acute alcoholism 4) depressed vital signs 5) obstetric patients 6) neonates
    • PC: 1) psychoses 2) depression 3) myasthenia gravis 4) COPD. (Due to a short half-life of the drug, seizure activity may recur.)
  12. Ind: 1) major motor seizures 2) status epilepticus 3) premedication before cardioversion 4) muscle tremors due to injury 5) acute anxiety
    CI: 1) shock 2) coma 3) acute alcoholism 4) depressed vital signs 5) obstetric patients 6) neonates
    PC: 1) psychoses 2) depression 3) myasthenia gravis 4) COPD. (Due to a short half-life of the drug, seizure activity may recur.)
    DIAZEPAM
  13. ETOMIDATE
    • Ind: Induce sedation for rapid sequence intubation.
    • CI: none
    • PC: 1) marked hypotension 2) severe asthma 3) severe cardiovascular disease
  14. Ind: Induce sedation for rapid sequence intubation. CI: none
    PC: 1) marked hypotension 2) severe asthma 3) severe cardiovascular disease
    ETOMIDATE
  15. FLUMAZENIL
    • Ind: respiratory depression secondary to the benzodiazepines.
    • CI: 1) hypersensitivity to flumazenil or benzodiazepines 2) patients who take medication for status epilepticus or seizures 3) seizure-prone patients during labor and delivery 4) tricyclic antidepressant overdose
    • PC: 1) hepatic impairment 2) elderly 3) pregnancy 4) nursing mothers 5) head injury 6) alcohol and drug dependency 7) physical dependence on benzodiazepines
  16. Ind: respiratory depression secondary to the benzodiazepines.
    CI: 1) hypersensitivity to flumazenil or benzodiazepines 2) patients who
    take medication for status epilepticus or seizures 3) seizure-prone
    patients during labor and delivery 4) tricyclic antidepressant overdose
    PC: 1) hepatic impairment 2) elderly 3) pregnancy 4) nursing mothers 5) head injury 6) alcohol and drug dependency 7) physical dependence on
    benzodiazepines
    FLUMAZENIL
  17. MIDAZOLAM
    • Ind: to induce sedation before cardioversion or intubation
    • CI: 1) hypersensitivity to benzodiazepines 2) narrow-angle glaucoma 3) shock 4) coma 5) acute alcohol intoxication
    • PC: 1) COPD 2) renal impairment 3) CHF 4) elderly
  18. Ind: to induce sedation before cardioversion or intubation
    CI: 1) hypersensitivity to benzodiazepines 2) narrow-angle glaucoma 3) shock 4) coma 5) acute alcohol intoxication
    PC: 1) COPD 2) renal impairment 3) CHF 4) elderly
    MIDAZOLAM
  19. SUCCINYLCHOLINE
    • Ind: facilitated endotracheal intubation
    • CI: 1) family history of malignant hyperthermia 2) penetrating eye injury 3) narrow-angle glaucoma 4) hyperkalemia
    • PC: 1) severe burn 2) crush injury 3) spinal cord injury
  20. Ind: facilitated endotracheal intubation
    CI: 1) family history of malignant hyperthermia 2) penetrating eye injury 3) narrow-angle glaucoma 4) hyperkalemia
    PC: 1) severe burn 2) crush injury 3) spinal cord injury
    SUCCINYLCHOLINE
  21. ADENOSINE
    • Ind: narrow, complex paroxysmal supraventricular tachycardia refractory tovagal maneuvers.
    • CI: 1)2nd & 3rd degree heart block 2)sinus node disease 3)asthma.
    • PC: may cause transient dysrhythmias - especially asystole, COPD.
  22. Ind: narrow, complex paroxysmal supraventricular tachycardia refractory tovagal maneuvers.
    CI: 1)2nd & 3rd degree heart block 2)sinus node disease 3)asthma.
    PC: may cause transient dysrhythmias - especially asystole, COPD.
    ADENOSINE
  23. EPINEPHRINE
    • Ind: 1)restore rhythm in cardiac arrest 2)severe allergic reactions
    • CI: 1)narrow angle glaucoma 2)hemorrhagic, traumatic, or cardiac shock 3)during labor
    • PC: none
  24. Ind: 1)restore rhythm in cardiac arrest 2)severe allergic reactions
    CI: 1)narrow angle glaucoma 2)hemorrhagic, traumatic, or cardiac shock 3)during labor
    PC: none
    EPINEPHRINE
  25. VASOPRESSIN
    • Ind: 1)to increase peripheral vascular resistance in arrest (CPR) 2)control bleeding from esophageal varices
    • CI: 1)PVCs 2)1st stage of labor.
    • PC: 1)epilepsy 2)migraine 3)heart failure 4)angina 5)vascular disease 6)hepatic impairment 7)elderly 8)children
  26. Ind: 1)to increase peripheral vascular resistance in arrest (CPR) 2)control bleeding from esophageal varices
    CI: 1)PVCs 2)1st stage of labor.
    PC: 1)epilepsy 2)migraine 3)heart failure 4)angina 5)vascular disease 6)hepatic impairment 7)elderly 8)children
    VASOPRESSIN
  27. ATROPINE
    • Ind: 1)hemodynamically significant bradycardia 2) brady asystolic arrest 3)organophosphate poisoning
    • CI: none in emergency setting. 2nd degree type 2 & above heart blocks are class 2B (not recommended)
    • PC: 1) AMI 2)glaucoma
  28. Ind: 1)hemodynamically significant bradycardia 2) brady asystolic arrest 3)organophosphate poisoning
    CI: none in emergency setting. 2nd degree type 2 & above heart blocks are class 2B (not recommended)
    PC: 1) AMI 2)glaucoma
    ATROPINE
  29. Asperin
    • Ind: Chest pain suggestive of an MI.
    • CI: 1)hypersensitivity to salicylates 2)active ulcer disease 3)asthma.
    • PC: bleeding disorders
  30. Ind: Chest pain suggestive of an MI.
    CI: 1)hypersensitivity to salicylates 2)active ulcer disease 3)asthma.
    PC: bleeding disorders
    Asperin
  31. Dextrose 50% in Water
    • Ind: hypoglycemia
    • CI: none in hypoglycemia
    • PC: 1)increased ICP 2)determine blood glucose level before administration 3)ensure good venous access
  32. Ind: hypoglycemia
    CI: none in hypoglycemia
    PC: 1)increased ICP 2)determine blood glucose level before administration 3)ensure good venous access
    Dextrose 50% in Water
  33. Furosemide
    • Ind: 1)congestive heart failure 2)pulmonary edema.
    • CI: hypotension
    • PC: 1)hepatic impairment 2)nephrotic syndrome 3)cardiogenic shock associated w/ acute MI 4)gout 5)PTs receiving digitalis or potassium-depleting steroids.
  34. Ind: 1)congestive heart failure 2)pulmonary edema.
    CI: hypotension
    PC: 1)hepatic impairment 2)nephrotic syndrome
    3)cardiogenic shock associated w/ acute MI 4)gout 5)PTs receiving digitalis or potassium-depleting steroids.
    Furosemide
  35. Nitroglycerin
    • Ind: 1)chest pain associated w/ angina & acute myocardial infarction, 2)acute pulmonary edema.
    • CI: 1)hypersensitivity 2)tolerance to nitrates 3)severe anemia 4)head trauma 5)hypotension 6)increased ICP 7)PTs taking sildenafil 8)glaucoma 9)shock
    • PC: 1)may induce servere headache 2)nitroglycerin is light sensitive & will lose potency when exposed to the air.
  36. Ind: 1)chest pain associated w/ angina & acute myocardial infarction, 2)acute pulmonary edema.
    CI: 1)hypersensitivity 2)tolerance to nitrates 3)severe anemia 4)head trauma 5)hypotension 6)increased ICP 7)PTs taking sildenafil 8)glaucoma 9)shock
    PC: 1)may induce servere headache 2)nitroglycerin is light sensitive & will lose potency when exposed to the air.
    Nitroglycerin
  37. Dobutamine
    • Ind: increase cardiac output in CHF/cardiogenic shock
    • CI: 1)hypersensitivity to Sympathomimetic amines 2)ventricular tachycardia 3)hypovolemia without fluid resuscitation
    • PC: 1)atrial fibrillation 2)preexisting hypertension
  38. Ind: increase cardiac output in CHF/cardiogenic shock
    CI: 1)hypersensitivity to Sympathomimetic amines 2)ventricular tachycardia 3)hypovolemia without fluid resuscitation
    PC: 1)atrial fibrillation 2)preexisting hypertension
    Dobutamine
  39. Dopamine
    • Ind: Nonhypovolemic hypotension (70 to 100 mmHg) & cardiogenic shock
    • CI: 1)hypovolemic hypotension w/out aggressive fluid resuscitation 2) tachydysrhythmias 3) ventricular fibrillation 4)pheochromocytoma
    • PC: 1)occlusive vascular disease 2)cold injury 3)arterial embolism 4)ensure adequate fluid resuscitation of the hypovolemic PT
  40. Ind: Nonhypovolemic hypotension (70 to 100 mmHg) & cardiogenic shock
    CI: 1)hypovolemic hypotension w/out aggressive fluid resuscitation 2) tachydysrhythmias 3) ventricular fibrillation 4)pheochromocytoma
    PC: 1)occlusive vascular disease 2)cold injury 3)arterial embolism 4)ensure adequate fluid resuscitation of the hypovolemic PT
    Dopamine
  41. Isoprotenerol
    • Ind: bradycardia refractory to atropine when pacing is not available
    • CI: cardiogenic shock
    • PC: tachydysrhythmias & those associated w/ digitalis & acute myocardial infarction
  42. Ind: bradycardia refractory to atropine when pacing is not available
    CI: cardiogenic shock
    PC: tachydysrhythmias & those associated w/ digitalis & acute myocardial infarction
    Isoprotenerol
  43. Tetracaine
    • Ind: eye injuries or foreign body
    • CI: hypersensitivity
    • PC: 1)be monitored 2)hyperthyroid disease 3)cardiac diseases
  44. Ind: eye injuries or foreign body
    CI: hypersensitivity
    PC: 1)be monitored 2)hyperthyroid disease 3)cardiac diseases
    Tetracaine
  45. Amiodarone
    • Ind: 1)life-threatening ventricular & supraventricular dysrhythmias 2)frequently atrial fibrillation.
    • CI: 1)cardiogenic shock 2)severe sinus bradycardia 3)advanced heart block.
    • PC: none
  46. Ind: 1)life-threatening ventricular & supraventricular dysrhythmias 2)frequently atrial fibrillation.
    CI: 1)cardiogenic shock 2)severe sinus bradycardia 3)advanced heart block.
    PC: none
    Amiodarone
  47. Bretylium
    • Ind: ventricular fibrillation & ventricular tachycardia refractory to lidocaine
    • CI: none
    • PC: 1)digitalized patients 2)digitalis-induced dysrhythmias
  48. Ind: ventricular fibrillation & ventricular tachycardia refractory to lidocaine
    CI: none
    PC: 1)digitalized patients 2)digitalis-induced dysrhythmias
    Bretylium
  49. Lidocaine
    • Ind: 1)pulseless ventricular tachycardia 2)ventricular fibrillation 3)ventricular tachycardia (w/ pulse)
    • CI: 1)hypersensitivity to amide-type local anesthetics 2)supraventricular dysrhythmias 3)stokes-adams syndrome 4)2nd- & 3rd-degree heart blocks 5)bradycardias
    • PC: 1)hepatic or renal impairment 2)CHF 3)hypoxia 4)respiratory depression 5)hypovolemia 6)myasthenia gravis 7)shock 8)elderly
  50. Ind: 1)pulseless ventricular tachycardia 2)ventricular fibrillation 3)ventricular tachycardia (w/ pulse)
    CI: 1)hypersensitivity to amide-type local anesthetics 2)supraventricular dysrhythmias 3)stokes-adams syndrome 4)2nd- & 3rd-degree heart blocks 5)bradycardias
    PC: 1)hepatic or renal impairment 2)CHF 3)hypoxia 4)respiratory depression 5)hypovolemia 6)myasthenia gravis 7)shock 8)elderly
    Lidocaine
  51. Procainamide
    • Ind: ventricular fibrillation and pulseless ventricular tachycardia refractory to lidocaine.
    • CI: hypersensitivity to procainamide or procaine, myasthenia gravis, & 2nd- or 3rd-degree heart block.
    • PC: hypotension, cardiac enlargement, CHF, AMI, ventricular dysrhythmias from digitalis, hepatic or renal impairment, or bronchial asthma.
  52. Ind: ventricular fibrillation and pulseless ventricular tachycardia refractory to lidocaine.
    CI: hypersensitivity to procainamide or procaine, myasthenia gravis, & 2nd- or 3rd-degree heart block.
    PC: hypotension, cardiac enlargement, CHF, AMI, ventricular dysrhythmias
    from digitalis, hepatic or renal impairment, or bronchial asthma.
    Procainamide
  53. DILTIAZEM
    • Ind: supraventricular tachydysrhythmias (atrial fibrillation, atrial flutter, & PSVT refractory to adenosine) & to increase coronary artery perfusion in angina.
    • CI: 1) hypersensitivity 2)sick sinus syndrome 3)2nd or 3rd degree HB 4)systolic BP < 90, diastolic BP < 60 5)wide-complex tachycardia 6)WPW
    • PC: CHF (especially with beta blockers)
  54. Ind: supraventricular tachydysrhythmias (atrial fibrillation, atrial flutter, & PSVT refractory to adenosine) & to increase coronary artery perfusion in angina.
    CI: 1) hypersensitivity 2)sick sinus syndrome 3)2nd or 3rd degree HB 4)systolic BP < 90, diastolic BP < 60 5)wide-complex tachycardia
    6)WPW
    PC: CHF (especially with beta blockers)
    DILTIAZEM
  55. TRIDIL
    • Ind: help relieve the pain associated with angina that does not respond to oral (by mouth) treatment; to control blood pressure; & help treat CHF
    • CI: hypotension, uncorrected hypovolemia, increased intracranial pressure, constrictive pericarditis & pericardial tamponade
    • PC: headache, severe hypotension, reflex tachycardia
  56. Ind: help relieve the pain associated with angina that does not respond to oral (by mouth) treatment; to control blood pressure; & help treat CHF
    CI: hypotension, uncorrected hypovolemia, increased intracranial pressure, constrictive pericarditis & pericardial tamponade
    PC: headache, severe hypotension, reflex tachycardia
    TRIDIL
  57. VERAPAMIL
    • Ind: PSVT refractory to adenosine, atrial flutter, & atrial fibrillation w/ rapid ventricular response
    • CI: severe hypotension, cardiogenic shock, 2nd or 3rd degree heart block, CHF, sinus node disease, & accessory AV pathways, WPW syndrome. It should not be administered to persons taking beta blockers
    • PC: none
  58. Ind: PSVT refractory to adenosine, atrial flutter, & atrial fibrillation w/ rapid ventricular response
    CI: severe hypotension, cardiogenic shock, 2nd or 3rd degree heart
    block, CHF, sinus node disease, & accessory AV pathways, WPW
    syndrome. It should not be administered to persons taking beta blockers
    PC: none
    VERAPAMIL
  59. METOPROLOL
    • Ind: AMI
    • CI: 1)cardiogenic shock 2)sinus bradycardia <45 3)2nd & 3rd degree HB 4)PR interval >0.24 5)asthma or COPD
    • PC: 1) hypersensitivity 2)hepatic or renal impairment 3)cardiomegaly 4)CHF controlled by digitalis & diuretics 5)AV conduction defects 6)thyrotoxicosis 7)diabetics 8)peripheral vascular disease
  60. Ind: AMI
    CI: 1)cardiogenic shock 2)sinus bradycardia <45 3)2nd & 3rd degree HB 4)PR interval >0.24 5)asthma or COPD
    PC: 1) hypersensitivity 2)hepatic or renal impairment 3)cardiomegaly 4)CHF controlled by digitalis & diuretics 5)AV conduction defects 6)thyrotoxicosis 7)diabetics 8)peripheral vascular disease
    METOPROLOL
  61. Activated Charcoal
    • Ind: acute ingested poisoning
    • CI: none
    • PC: administer only after emesis or in those cases where emesis is CI
  62. Ind: acute ingested poisoning
    CI: none
    PC: administer only after emesis or in those cases where emesis is CI
    Activated Charcoal
  63. Calcium Chloride
    • Ind: hyperkalemia, hypocalcemia, hypermagnesemia, & calcium channel blocker toxicity
    • CI: ventricular fibrillation, hypercalcemia, & possible digitalis toxicity
    • PC: may precipitate toxicity in PTs taking digoxin. ensure the IV line is in a large vein & flushed before using & after calcium
  64. Ind: hyperkalemia, hypocalcemia, hypermagnesemia, & calcium channel blocker toxicity
    CI: ventricular fibrillation, hypercalcemia, & possible digitalis toxicity
    PC: may precipitate toxicity in PTs taking digoxin. ensure the IV line is in a large vein & flushed before using & after calcium
    Calcium Chloride
  65. Methylprednisolone
    • Ind: spinal cord injury, asthma, severe anaphylaxis, COPD.
    • CI: no major CIs in the emergency setting.
    • PC: only a single dose should be given in the prehospital setting.
  66. Ind: spinal cord injury, asthma, severe anaphylaxis, COPD.
    CI: no major CIs in the emergency setting.
    PC: only a single dose should be given in the prehospital setting.
    Methylprednisolone
  67. MAGNESIUM SULFATE
    • Ind: 1)refractory V-Fib 2)pulseless V-Tach (especially torsade depointes) 3)AMI 4)eclamptic seizures.
    • CI: 1)HB 2)myocardial damage 3)shock 4)persistent hypertension 5)hypocalcemia.
    • PC: 1)other CNS depressants 2)neuromuscular blocking agents.
  68. Ind: 1)refractory V-Fib 2)pulseless V-Tach (especially torsade depointes) 3)AMI 4)eclamptic seizures.
    CI: 1)HB 2)myocardial damage 3)shock 4)persistent hypertension 5)hypocalcemia.
    PC: 1)other CNS depressants 2)neuromuscular blocking agents.
    MAGNESIUM SULFATE
  69. PHENYTOIN
    • Ind: 1)seizures 2)status epilepticus 3)cardiac dysrhythmias secondary to digitalis toxicity.
    • CI: 1)hypersensitivity to hydantoin products 2)seizures due to hypoglycemia 3)sinus bradycardia 4)HB 5)Adams-Stokes syndrome.
    • PC: 1)hepatic or renal impairment 2)alcoholism 3)cardiogenic shock 4)elderly 5)debilitated patients 6)diabetes 7)hyperglycemia 8)bradycardia 9)HB 10)respiratory depression
  70. Ind: 1)seizures 2)status epilepticus 3)cardiac dysrhythmias secondary to digitalis toxicity.
    CI: 1)hypersensitivity to hydantoin products 2)seizures due to hypoglycemia 3)sinus bradycardia 4)HB 5)Adams-Stokes syndrome.
    PC: 1)hepatic or renal impairment 2)alcoholism 3)cardiogenic shock
    4)elderly 5)debilitated patients 6)diabetes 7)hyperglycemia
    8)bradycardia 9)HB 10)respiratory depression
    PHENYTOIN
  71. SODIUM BICARBONATE
    • Ind: 1)tricyclic antidepressant and barbiturate overdose 2)refractory acidosis 3)hyperkalemia.
    • CI: none when used in severe hypoxia or late cardiac arrest.
    • PC: 1)may cause alkalosis if given in too large a quantity 2)may deactivate vasopressors 3)may precipitate w/ calcium chloride.
  72. Ind: 1)tricyclic antidepressant and barbiturate overdose 2)refractory acidosis 3)hyperkalemia.CI: none when used in severe hypoxia or late cardiac arrest.PC: 1)may cause alkalosis if given in too large a quantity 2)may deactivate vasopressors 3)may precipitate w/ calcium chloride.
    SODIUM BICARBONATE
  73. THIAMINE
    • Ind: 1)coma of unknown origin 2)chronic alcoholism w/ associated coma 3)delirium tremens.
    • CI: none.
    • PC: known hypersensitivity to the drug.
  74. Ind: 1)coma of unknown origin 2)chronic alcoholism w/ associated coma 3)delirium tremens.
    CI: none.
    PC: known hypersensitivity to the drug.
    THIAMINE
  75. DIPHENHYDRAMINE
    • Ind: 1)anaphylaxis 2)allergic reactions 3)dystonic reactions
    • CI: asthma and other lower respiratory diseases
    • PC: may induce 1)hypotension 2)headache 3)palpitations 4)tachycardia 5)sedation 6)drowsiness 7)disturbed coordination
  76. Ind: 1)anaphylaxis 2)allergic reactions 3)dystonic reactions
    CI: asthma and other lower respiratory diseases
    PC: may induce 1)hypotension 2)headache 3)palpitations 4)tachycardia 5)sedation 6)drowsiness 7)disturbed coordination
    DIPHENHYDRAMINE
  77. LORAZEPAM
    • Ind: sedation for cardioversion and status epilepticus
    • CI: sensitivity to benzodiazepines
    • PC: 1)narrow-angle glaucoma 2)depression 3)psychosis 4)coma 5)shock 6)acute alcohol intoxication 7)renal or hepatic impairment 8)organic brain syndrome 9)myasthenia gravis 10)GI disorders 11)elderly 12)debilitated 13)limited pulmonary reserve
  78. Ind: sedation for cardioversion and status epilepticusCI: sensitivity to benzodiazepinesPC:
    1)narrow-angle glaucoma 2)depression 3)psychosis 4)coma 5)shock 6)acute
    alcohol intoxication 7)renal or hepatic impairment 8)organic brain
    syndrome 9)myasthenia gravis 10)GI disorders 11)elderly 12)debilitated
    13)limited pulmonary reserve
    LORAZEPAM
  79. METOCLOPRAMIDE
    • Ind: nausea &amp; vomiting
    • CI: 1)hypersensitivity 2)allergy to sulfite agents 3)seizure disorders 4)pheochromocytoma 5)mechanical GI obstruction or perforation 6)breast cancer
    • PC: 1)CHF 2)hypokalemia 3)renal impairment 4)GI hemorrhage 5)intermittent porphyria
  80. Ind: nausea &amp; vomitingCI: 1)hypersensitivity 2)allergy to
    sulfite agents 3)seizure disorders 4)pheochromocytoma 5)mechanical GI
    obstruction or perforation 6)breast cancerPC: 1)CHF 2)hypokalemia 3)renal impairment 4)GI hemorrhage 5)intermittent porphyria
    METOCLOPRAMIDE
  81. ZOFRAN
    • Des: selective blocking agent of the serotonin 5-HT3 receptor type
    • Ind: prevention of nausea &amp; intractible vomiting
    • CI: None
    • PC: may mask a progressive ileus &amp;/or gastric distension
  82. Des: selective blocking agent of the serotonin 5-HT3 receptor type
    Ind: prevention of nausea &amp; intractible vomiting
    CI: None
    PC: may mask a progressive ileus &amp;/or gastric distension
    ZOFRAN
  83. CHLORDIAZEPOXIDE
    • Des: benzodiazepine derivative that produces 1)mild sedation 2)anticonvulsant 3)skeletal muscle relaxant 4)prolonged hypnotic effects
    • Ind: 1)severe anxiety &amp; tension 2)acute alcohol withdrawal symptoms (DTs)
    • CI: 1)hypersensitivity to benzodiazepines 2)pregnant and nursing mothers 3)children under 6
    • PC: 1)primary depressive disorders or psychoses 2)acute alcohol intoxication
  84. Des: benzodiazepine derivative that produces 1)mild sedation
    2)anticonvulsant 3)skeletal muscle relaxant 4)prolonged hypnotic effectsInd: 1)severe anxiety &amp; tension 2)acute alcohol withdrawal symptoms (DTs)CI: 1)hypersensitivity to benzodiazepines 2)pregnant and nursing mothers 3)children under 6PC: 1)primary depressive disorders or psychoses 2)acute alcohol intoxication
    CHLORDIAZEPOXIDE

What would you like to do?

Home > Flashcards > Print Preview